A Generous Investment Helps Advance the Fight for a Cancer Cure
Basic research scientists study how cells work and diseases progress. Their discoveries form the foundation upon which all other research is built. Their work saves lives.
The Wistar Institute’s Cancer Center has now been renamed the Ellen and Ronald Caplan Cancer Center because of a $10 million investment to foster the innovation of our world-leading scientists in their quest to detect, treat and defeat cancer.
Due to the generosity of Philadelphia philanthropists Ellen and Ronald Caplan, this transformative gift will advance life-changing breakthroughs toward next-generation cancer therapies for people around the globe. Wistar will now be among the few named National Cancer Institute (NCI)-designated basic research cancer centers in the U.S. The investment will also further Philadelphia’s growing recognition as a life science innovation hub.
Celebrating 50 Years of Cancer Research Excellence as an NCI-designated Cancer Center, The Ellen and Ronald Caplan Cancer Center will continue its trajectory of groundbreaking innovation in the prevention and treatment of cancer and the recruitment of new leaders in cancer research.
Take a journey into the vision of the Ellen and Ronald Caplan Cancer Center.
“Despite recent progress, cancer is still a feared disease carrying enormous morbidity and mortality for patients and their families. Ellen and Ron’s vision is to change that.”
-Dario C. Altieri, M.D., president and CEO of The Wistar Institute, director of the Ellen and Ronald Caplan Cancer Center, and Robert and Penny Fox Distinguished ProfessorThis post was produced and paid for by The Ellen and Ronald Caplan Cancer Center of The Wistar Institute